236 related articles for article (PubMed ID: 2423655)
1. Serial levels of CA 19-9 and CEA in colonic cancer.
Novis BH; Gluck E; Thomas P; Steele GD; Zurawski VR; Stewart R; Lavin PT; Zamcheck N
J Clin Oncol; 1986 Jun; 4(6):987-93. PubMed ID: 2423655
[TBL] [Abstract][Full Text] [Related]
2. Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases.
Kuusela P; Jalanko H; Roberts P; Sipponen P; Mecklin JP; Pitkänen R; Mäkelä O
Br J Cancer; 1984 Feb; 49(2):135-9. PubMed ID: 6582896
[TBL] [Abstract][Full Text] [Related]
3. Significance of measurement of a carbohydrate antigenic determinant 19-9 (CA 19-9) for monitoring colorectal cancer patients.
Tomoda H; Furusawa M
Jpn J Surg; 1986 Jan; 16(1):73-5. PubMed ID: 2421035
[TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation of CEA in colorectal carcinoma].
Shimoyama T; Fukuda Y; Itoh S; Shimizu T; Kawaguchi A; Mori M; Ishii T; Miura T; Tomita M
Gan No Rinsho; 1985 May; 31(6 Suppl):648-54. PubMed ID: 3897618
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of combined CA-19-9 and CEA assay in monitoring recurrences and metastases of colorectal cancer].
Yu BM
Zhonghua Wai Ke Za Zhi; 1992 Dec; 30(12):707-9, 777. PubMed ID: 1339738
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic value of tumor markers in cases of colorectal cancer: CEA and CA 19-9].
Desaive C; Servais R; Collette J; Denis D; Reginster JY; Franchimont P
Acta Gastroenterol Belg; 1987; 50(1):65-78. PubMed ID: 3480671
[No Abstract] [Full Text] [Related]
7. [Comparison of the tumor markers CEA and CA 19-9 in colorectal diagnosis].
Heptner G; Domschke S; Krapf F; Schneider MU; Iro H; Domschke W
Dtsch Med Wochenschr; 1984 Aug; 109(35):1309-12. PubMed ID: 6590287
[TBL] [Abstract][Full Text] [Related]
8. [Determination of carcinoembryonic and carbohydrate antigens in the diagnosis of recurrences and metastases of rectal cancer].
Ozhiganov EL; Kuznetsova LF
Med Radiol (Mosk); 1986 Aug; 31(8):40-4. PubMed ID: 3462448
[TBL] [Abstract][Full Text] [Related]
9. Follow-up of colorectal cancer resected for cure. An experience with CEA, TPA, Ca 19-9 analysis and second-look surgery.
Fucini C; Tommasi SM; Rosi S; Malatantis G; Cardona G; Panichi S; Bettini U
Dis Colon Rectum; 1987 Apr; 30(4):273-7. PubMed ID: 3470172
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9.
Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
Eur J Surg Oncol; 1987 Jun; 13(3):197-201. PubMed ID: 3474158
[TBL] [Abstract][Full Text] [Related]
11. CEA radioimmunoassay. Clinical applications in colorectal cancer.
Huyghe J
Acta Chir Belg; 1983; 83(2):77-88. PubMed ID: 6858539
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of the determination of serum carbohydrate antigen 19-9 in patients with carcinoma of the stomach and colorectum].
Hamazoe R; Yoshioka H; Furumoto T; Kanayama H; Shimizu N; Maeta M; Koga S
Gan No Rinsho; 1985 Aug; 31(10):1287-92. PubMed ID: 3863968
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].
Lorenz M; Happ J; Hottenrott C; Maul FD; Baum RP; Hör G; Encke A
Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133
[TBL] [Abstract][Full Text] [Related]
14. A study of the reliability of carcinoembryonic antigen blood levels in following the course of colorectal cancer.
Armitage NC; Davidson A; Tsikos D; Wood CB
Clin Oncol; 1984 Jun; 10(2):141-7. PubMed ID: 6375928
[TBL] [Abstract][Full Text] [Related]
15. Serum CA 242 and CEA detect different patients with recurrent colorectal cancer.
Carpelan-Holmström MA; Haglund CH; Järvinen HJ; Roberts PJ
Anticancer Res; 1996; 16(2):981-6. PubMed ID: 8687164
[TBL] [Abstract][Full Text] [Related]
16. CEA-directed second-look surgery in the asymptomatic patient after primary resection of colorectal carcinoma.
Martin EW; Minton JP; Carey LC
Ann Surg; 1985 Sep; 202(3):310-7. PubMed ID: 4037904
[TBL] [Abstract][Full Text] [Related]
17. Carcinoembryonic antigen: clinical and historical aspects.
Martin EW; Kibbey WE; DiVecchia L; Anderson G; Catalano P; Minton JP
Cancer; 1976 Jan; 37(1):62-81. PubMed ID: 1247968
[TBL] [Abstract][Full Text] [Related]
18. Colon-specific antigen-p (CSAp). I. Initial clinical evaluation as a marker for colorectal cancer.
Pant KD; Shochat D; Nelson MO; Goldenberg DM
Cancer; 1982 Sep; 50(5):919-26. PubMed ID: 6178498
[TBL] [Abstract][Full Text] [Related]
19. Measurement of a monoclonal-antibody-defined antigen (CA19-9) in the sera of patients with malignant and nonmalignant diseases. Comparison with carcinoembryonic antigen.
Gupta MK; Arciaga R; Bocci L; Tubbs R; Bukowski R; Deodhar SD
Cancer; 1985 Jul; 56(2):277-83. PubMed ID: 2408729
[TBL] [Abstract][Full Text] [Related]
20. The value of CA 19-9 in gastric and colorectal carcinoma.
Safi F; Bittner R; Roscher R; Kübel R; Beger HG
Cancer Invest; 1987; 5(5):401-7. PubMed ID: 3480768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]